highlighted the central role of MUC1 in colorectal cancer stem cell vaccine immunotherapy, impacting tumor growth and metastasis, particularly notable in enhancing NK cell toxicity and promoting anti-MUC1 antibody generation (169). This evidence concerns the gene MUC1 and neoplasm.